Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgios Gakis

Showing results (1-10 of 193) with videos related to

Pageof 20
Sort By:
European Urology|October 2, 2024
Re: Immune Contexture Changes Following Blue Light Cystoscopy with Hexaminolevulinate in Bladder CancerGeorgios Gakis
The Journal of Urology|January 19, 2016
Editorial CommentGeorgios Gakis
Der Urologe. Ausg. A|October 15, 2021
[Prophylaxis of recurrence in low-to-intermediate risk non-muscle invasive bladder cancer (NMIBC)]Georgios Gakis
The Journal of Urology|July 10, 2019
Editorial CommentGeorgios Gakis
European Urology|March 18, 2019
Re: Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized TrialGeorgios Gakis
European Urology Focus|January 29, 2020
Management of Muscle-invasive Bladder Cancer in the 2020s: Challenges and PerspectivesGeorgios Gakis
The Journal of Urology|March 29, 2017
Editorial CommentGeorgios Gakis
International Journal of Urology : Official Journal of the Japanese Urological Association|November 21, 2013
Editorial Comment to Docetaxel, cisplatin and 5-fluorouracil chemotherapy with concurrent radiation for unresectable advanced urethral carcinomaGeorgios Gakis
International Journal of Urology : Official Journal of the Japanese Urological Association|September 1, 2012
Editorial Comment to CD74 expression is increased in high-grade, invasive urothelial carcinoma of the bladderGeorgios Gakis
European Urology|June 30, 2016
Re: Vinflunine-gemcitabine Versus Vinflunine-carboplatin as First-line Chemotherapy in Cisplatin-unfit Patients with Advanced Urothelial Carcinoma: Results of an International Randomized Phase II Trial (JASINT1)Georgios Gakis
Pageof 20

Showing results (1-10 of 193) with videos related to

Sort By:
Pageof 20
European Urology|October 2, 2024
Re: Immune Contexture Changes Following Blue Light Cystoscopy with Hexaminolevulinate in Bladder CancerGeorgios Gakis
The Journal of Urology|January 19, 2016
Editorial CommentGeorgios Gakis
Der Urologe. Ausg. A|October 15, 2021
[Prophylaxis of recurrence in low-to-intermediate risk non-muscle invasive bladder cancer (NMIBC)]Georgios Gakis
The Journal of Urology|July 10, 2019
Editorial CommentGeorgios Gakis
European Urology|March 18, 2019
Re: Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized TrialGeorgios Gakis
European Urology Focus|January 29, 2020
Management of Muscle-invasive Bladder Cancer in the 2020s: Challenges and PerspectivesGeorgios Gakis
The Journal of Urology|March 29, 2017
Editorial CommentGeorgios Gakis
International Journal of Urology : Official Journal of the Japanese Urological Association|November 21, 2013
Editorial Comment to Docetaxel, cisplatin and 5-fluorouracil chemotherapy with concurrent radiation for unresectable advanced urethral carcinomaGeorgios Gakis
International Journal of Urology : Official Journal of the Japanese Urological Association|September 1, 2012
Editorial Comment to CD74 expression is increased in high-grade, invasive urothelial carcinoma of the bladderGeorgios Gakis
European Urology|June 30, 2016
Re: Vinflunine-gemcitabine Versus Vinflunine-carboplatin as First-line Chemotherapy in Cisplatin-unfit Patients with Advanced Urothelial Carcinoma: Results of an International Randomized Phase II Trial (JASINT1)Georgios Gakis
Pageof 20